Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treximet in the Prevention and Modification of Disease Progression in Migraine
NCT01300546Phase 4Completed
- Start
- Dec 2010
- Primary completion
- Apr 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of sumatriptan in migraine (2 arms). Primary endpoint: Percent Change of Headache Days Compared to Baseline at Day 121. Started Dec 2010; status: completed.
02
Drugs
sumatriptan
03
Conditions
migraine
Beyond the preview
Go deeper on NCT01300546.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01300546.